Drugs & Therapy Perspectives

, Volume 34, Issue 11, pp 513–516 | Cite as

Follow gentle cleansing practices to minimize the development of incontinence-associated dermatitis in the elderly

  • Adis Medical WritersEmail author
Disease Management


Elderly patients with urinary or faecal incontinence are highly susceptible to incontinence-associated dermatitis (IAD), particularly those in clinical and geriatric care settings. Prolonged exposure to urinary and faecal matter further weakens their fragile dermis, increasing the risk for injury from friction and other everyday abrasions. Following several key guiding principles, such as gentle skin cleansing, when caring for at-risk patients may prevent or minimize the risk of IAD development.


Compliance with ethical standards

Conflict of interest

The article was adapted from Drugs Aging 2018;35(1):1–10 [1] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.


The preparation of this review was not supported by any external funding.


  1. 1.
    Beele H, Smet S, Van Damme N, et al. Incontinence-associated dermatitis: pathogenesis, contributing factors, prevention and management options. Drugs Aging. 2018;35(1):1–10.CrossRefGoogle Scholar
  2. 2.
    Stalder JF, Tennstedt D, Deleuran M, et al. Fragility of epidermis and its consequence in dermatology. J Eur Acad Dermatol Venereol. 2014;28(Suppl 4):1–18.CrossRefGoogle Scholar
  3. 3.
    Pather P, Hines S. Best practice nursing care for ICU patients with incontinence-associated dermatitis and skin complications resulting from faecal incontinence and diarrhoea. Int J Evid Based Healthc. 2016;14(1):15–23.CrossRefGoogle Scholar
  4. 4.
    Leung FW, Schnelle JF. Urinary and fecal incontinence in nursing home residents. Gastroenterol Clin N Am. 2008;37(3):697–707.CrossRefGoogle Scholar
  5. 5.
    Jacobs JJ, Lehe CL, Hasegawa H, et al. Skin irritants and contact sensitizers induce Langerhans cell migration and maturation at irritant concentration. Exp Dermatol. 2006;15(6):432–40.CrossRefGoogle Scholar
  6. 6.
    Black JM, Gray M, Bliss DZ, et al. MASD part 2: incontinence-associated dermatitis and intertriginous dermatitis: a consensus. J Wound Ostomy Cont Nurs. 2011;38(4):359–70.CrossRefGoogle Scholar
  7. 7.
    Al-Nuaimi Y, Sherratt MJ, Griffiths CE. Skin health in older age. Maturitas. 2014;79(3):256–64.CrossRefGoogle Scholar
  8. 8.
    Fluhr JW, Dickel H, Kuss O, et al. Impact of anatomical location on barrier recovery, surface pH and stratum corneum hydration after acute barrier disruption. Br J Dermatol. 2002;146(5):770–6.CrossRefGoogle Scholar
  9. 9.
    Adam R. Skin care of the diaper area. Pediatr Dermatol. 2008;25(4):427–33.CrossRefGoogle Scholar
  10. 10.
    Mugita Y, Minematsu T, Huang L, et al. Histopathology of incontinence-associated skin lesions: inner tissue damage due to invasion of proteolytic enzymes and bacteria in macerated rat skin. PLoS One. 2015;10(9):e0138117.CrossRefGoogle Scholar
  11. 11.
    Beeckman D, Van den Bussche K, Alves P, et al. Towards an international language for incontinence-associated dermatitis (IAD): design and evaluation of psychometric properties of the Ghent Global IAD Categorization Tool (GLOBIAD) in 30 countries. Br J Dermatol. 2018;178(6):1331–40.CrossRefGoogle Scholar
  12. 12.
    Payne D. Not just another rash: management of incontinence-associated dermatitis. Br J Community Nurs. 2016;21(9):434–40.CrossRefGoogle Scholar
  13. 13.
    Beeckman D, Van Damme N, Schoonhoven L, et al. Interventions for preventing and treating incontinence-associated dermatitis in adults. Cochrane Database Syst Rev. 2016;11:CD011627.PubMedGoogle Scholar
  14. 14.
    Lichterfeld A, Hauss A, Surber C, et al. Evidence-based skin care: a systematic literature review and the development of a basic skin care algorithm. J Wound Ostomy Cont Nurs. 2015;42(5):501–24.CrossRefGoogle Scholar
  15. 15.
    Beeckman D, Van Lancker A, Van Hecke A, et al. A systematic review and meta-analysis of incontinence-associated dermatitis, incontinence, and moisture as risk factors for pressure ulcer development. Res Nurs Health. 2014;37(3):204–18.CrossRefGoogle Scholar
  16. 16.
    Loden M. Role of topical emollients and moisturizers in the treatment of dry skin barrier disorders. Am J Clin Dermatol. 2003;4(11):771–88.CrossRefGoogle Scholar
  17. 17.
    Lynde CW. Moisturizers: what they are and how they work. Skin Ther Lett. 2001;6(13):3–5.Google Scholar
  18. 18.
    Mostosi C, Simonart T. Effectiveness of barrier creams against irritant contact dermatitis. Dermatology. 2016;232(3):353–62.CrossRefGoogle Scholar
  19. 19.
    Sparr E, Millecamps D, Isoir M, et al. Controlling the hydration of the skin though the application of occluding barrier creams. J R Soc Interface. 2013;10(80):20120788.CrossRefGoogle Scholar
  20. 20.
    Del Rosso JQ. Incorporation of a barrier protection cream in the management of chronic hand dermatitis: focus on data supporting an established hand protectant formulation and modifications designed to assist in barrier repair. J Clin Aesthet Dermatol. 2014;7(2):40–8.PubMedPubMedCentralGoogle Scholar
  21. 21.
    Corazza M, Minghetti S, Bianchi A, et al. Barrier creams: facts and controversies. Dermatitis. 2014;25(6):327–33.CrossRefGoogle Scholar
  22. 22.
    Taylor C. Importance of nutrition in preventing and treating pressure ulcers. Nurs Older People. 2017;29(6):33–9.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  1. 1.SpringerAucklandNew Zealand

Personalised recommendations